of hepatitis C. Promega protocol using the dual luciferase reporter assay system as described previously (26). imidazole), and the bound proteins were eluted with elution buffer containing 500mM imidazole.
123
The eluted proteins were dialyzed in dialysis buffer (50mM Tris pH 7.4, 100mM KCl, 7mM β- 
128
Cells were harvested at different time points and total RNA was isolated using TRIzol reagent 129 (Sigma) followed by reverse transcriptase PCR (RT-PCR). Cell lysates were prepared by using
130
reporter lysis buffer (Promega) and luciferase activities were mesured using luciferase assay kit 131 (Promega).
132
Quantitative RT-PCR. For RT-PCR, 2 µg of total RNA was used for first strand cDNA 133 synthesis using RevertAid TM Moloney murine leukemia virus reverse transcriptase (M-MuLV
134
RT, Thermo Scientific). cDNA (1:10 diluted) was used for PCR amplification using SYBR
135
Green real time assay mixture (Thermo Scientific). The data were obtained by using an ABI-
136
Prism's real time PCR machine and analyzed using the comparative ΔΔC T method (27).
137
Amplification of Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal 
RESULTS

178
Role of different amino acid residues of 7-mer LaR2C-N7 in inhibiting HCV translation
179
Human La protein is known to interact with HCV RNA via a β-turn (176-180) present in the 10 were checked in an in vitro translation assay system. A considerable reduction of translation 186 inhibitory activity was observed in case of LaR2C-N7-2A, N7-3A, N7-4A, N7-5A and N7-6A,
187
but not for N7-1A and N7-7A, when compared to the wild-type peptide (Fig. 1) La protein (Fig. 3A) .
219
Next, we investigated if the results hold true within a mouse cell. For this, the non-replicative,
220
SGR-JFH1/GND RNA carrying a mutation in NS5B was used to exclude the differences due to (Fig. 4C) at longer time points (24, 48 and 72hr) after transfection. As 234 expected, increased replication was observed in the presence of hLa and mLahN7 (but not mLa).
235
In contrast, the level of SGR-JFH1/GND RNA rapidly declined even in presence of hLa or mLa- hybridization based methods to quantify negative strands levels, more sensitive strand-specific
256
RT-PCR using tagged primers (32) (Figs.6A-6C ) and two cycle RNase protection assay (Figs.
257
6D and 6E) were performed and HCV negative strands were detected. We found that 258 overexpression of hLa or mLahN7 (not mLa) enhances HCV negative strand synthesis, which 259 further strengthens our observation that the β-turn corresponding to human La is important for
260
HCV RNA replication in mouse cells. packaging, and assembly (17, (34) (35) (36) (37) 
